Clinical Trial Update: Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating hyperthermia in combination with an immune checkpoint inhibitor for advanced gastrointestinal tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Tumor

Snippet

Sponsor: Pengyuan Liu | Conditions: Gastrointestinal Tumor | Phase 1, Phase 2 | Status: COMPLETED